БИБЛИОТЕКА
- Фильтр
- Количество записей: 3012
- По дате
- По просмотрам
-
Зарубежные материалы
Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy
The efficacy of thiazolidinediones, as compared with other oral glucose-lowering medications, in maintaining long-term glycemic control in type 2 diabetes is not known.
Подробнее484
-
Зарубежные материалы
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Подробнее544
-
Зарубежные материалы
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
The cardiovascular effects of adding once-weekly treatment with exenatide to usual care in patients with type 2 diabetes are unknown.
Подробнее410
-
Зарубежные материалы
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
Data are lacking on the long-term effect on cardiovascular events of adding sitagliptin, a dipeptidyl peptidase 4 inhibitor, to usual care in patients with type 2 diabetes and cardiovascular disease.
Подробнее395
-
Зарубежные материалы
Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientifc evidence from across the world in 2007–2017
Te International Diabetes Federation (IDF) estimates that worldwide, 415 million people have diabetes, 91% of whom have type 2 diabetes mellitus (T2DM). People with diabetes comprise 8.8% of the world’s population, and IDF predicts that the number of cases of diabetes will rise to 642 million by 2040
Подробнее620
-
Зарубежные материалы
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetesd2019
The American Diabetes Association (ADA) “Standards of Medical Care in Diabetes” includes ADA’s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care.
Подробнее811
-
Зарубежные материалы
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and theEuropeanAssociation for the Study of Diabetes (EASD)
The American Diabetes Association and the European Association for the Study of Diabetes convened a panel to update the prior position statements, published in 2012 and 2015, on the management of type 2 diabetes in adults. A systematic evaluation of the literature since 2014 informed new recommendations. These include additional focus on lifestyle management and diabetes self-management education ...
Подробнее524
-
Зарубежные материалы
Structured lifestyle education for people with schizophrenia, schizoaffective disorder and first-episode psychosis (STEPWISE): randomised controlled trial
People with schizophrenia die 10–20 years earlier than the general population, with approximately 75% of deaths resulting from physical illness.1 The twofold increased prevalence of overweight and obesity contributes to this excess mortality.2 Some, but not all, studies suggest that dietary
Подробнее413
-
Зарубежные материалы
Chronic Kidney Disease and the Risk of End-Stage Renal Disease versus Death
In the United States, approximately one in three adults aged 65 years and older has chronic kidney disease (CKD), defined as an eGFR ...
Подробнее537
-
Зарубежные материалы
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
The Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology(ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD).
Подробнее409
-
Зарубежные материалы
Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus
Abstract—The American Heart Association (AHA) and the American Diabetes Association (ADA) have each published guidelines for cardiovascular disease prevention: The ADA has issued separate recommendations for each of the cardiovascular risk factors in patients with diabetes, and the AHA has shaped primary and secondary guidelines that extend to patients with diabetes. This statement will attempt to ...
Подробнее438
-
Зарубежные материалы
High prevalence of previously unknown heart failure and left ventricular dysfunction in patients with type 2 diabetes
Aims/hypothesis The aim of this study was to assess the prevalence of (unknown) heart failure and left ventricular dysfunction in older patients with type 2 diabetes.
Подробнее637
-
Зарубежные материалы
Obesity and Diabetic Kidney Disease
The prevalence of obesity (body mass index, BMI ≥ 30 kg/m2) has risen to epidemic proportions and continues to be a major health problem worldwide 1–3. The high prevalence of obesity is closely linked to the increased incidence of a number of chronic diseases, including type 2 diabetes, hypertension and cardiovascular disease 2, 4–8.
Подробнее709
-
Статьи
ЭКГ высокого разрешения в выборе антигипертензивной терапии у больных сахарным диабетом
Изучена прогностическая значимость ЭКГ высокого разрешения у больных сахарным диабетом, получавших моноприл и небиволол. Обследовано 138 больных сахарным диабетом с артериальной гипертензией и 60 больных сахарным диабетом без артериальной гипертензии путем анализа поздних потенциалов желудочков, проведен сравнительный анализ с больными, получавшими моноприл и небилет.
Подробнее422
-
Статьи
Особенности почечной патологии у больных сахарным диабетом 2 типа
Сахарный диабет [СД] 2 типа относится к числу наиболее распространенных заболеваний.
Подробнее505
- ← Предыдущая
- 1
- ...
- 116
- 117
- 118
- 119 (current)
- 120
- 121
- 122
- ...
- 201
- Следующая →